Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Article

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis

Olivier Marcy, Laurence Borand, Vibol Ung, Philippe Msellati, Mathurin Tejiokem, Khanh Truong Huu, Viet Do Chau, Duong Ngoc Tran, Francis Ateba-Ndongo, Suzie Tetang-Ndiang, Boubacar Nacro, Bintou Sanogo, Leakhena Neou, Sophie Goyet, Bunnet Dim, Polidy Pean, Catherine Quillet, Isabelle Fournier, Laureline Berteloot, Guislaine Carcelain, Sylvain Godreuil, Stéphane Blanche, Christophe Delacourt and ANRS 12229 PAANTHER 01 STUDY GROUP
Pediatrics September 2019, 144 (3) e20182065; DOI: https://doi.org/10.1542/peds.2018-2065
Olivier Marcy
aEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia;
bCentre INSERM U1219, Bordeaux Population Health, University of Bordeaux, Bordeaux, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurence Borand
aEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vibol Ung
cTuberculosis and HIV Department, National Pediatric Hospital, Phnom Penh, Cambodia;
dUniversity of Health Sciences, Phnom Penh, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Msellati
eUMI 233-U1175 TransVIHMI, IRD, Université de Montpellier, Montpellier, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathurin Tejiokem
fService d’Epidémiologie et de Santé Publique, Centre Pasteur du Cameroun, Réseau International des Instituts Pasteur, Yaounde, Cameroon;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khanh Truong Huu
gInfectious Disease Department, Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viet Do Chau
hInfectious Disease Department, Pediatric Hospital Nhi Dong 2, Ho Chi Minh City, Vietnam;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Duong Ngoc Tran
iPediatric Department, Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis Ateba-Ndongo
jCentre Mère et Enfant de la Fondation Chantal Biya, Yaounde, Cameroon;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzie Tetang-Ndiang
kService de Pédiatrie, Centre Hospitalier d’Essos, Yaounde, Cameroon;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boubacar Nacro
lService de Pédiatrie, Centre Hospitalier Universitaire Souro Sanou, Bobo Dioulasso, Burkina Faso;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bintou Sanogo
lService de Pédiatrie, Centre Hospitalier Universitaire Souro Sanou, Bobo Dioulasso, Burkina Faso;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leakhena Neou
mAngkor Hospital for Children, Siem Reap, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Goyet
aEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bunnet Dim
aEpidemiology and Public Health Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polidy Pean
nImmunology Laboratory, Institut Pasteur du Cambodge, Phnom Penh, Cambodia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Quillet
oANRS Research Site, Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Fournier
pInserm US19, Villejuif, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laureline Berteloot
qService de Radiologie Pédiatrique,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guislaine Carcelain
rImmunologie Biologique, Hôpital Robert Debré, Assistance Publique–Hôpitaux de Paris, Paris, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Godreuil
sDépartement de Bactériologie-Virologie, Hôpital Arnaud de Villeneuve, Centre Hospitalier Régional Universitaire de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphane Blanche
tUnité d’Immunologie Hématologie Rhumatologie Pédiatrique, Hôpital Necker Enfants Malades and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Delacourt
uService de Pneumologie et d’Allergologie Pédiatriques, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • Comments
Loading
Download PDF

Abstract

BACKGROUND: Diagnosis of tuberculosis should be improved in children infected with HIV to reduce mortality. We developed prediction scores to guide antituberculosis treatment decision in HIV-infected children with suspected tuberculosis.

METHODS: HIV-infected children with suspected tuberculosis enrolled in Burkina Faso, Cambodia, Cameroon, and Vietnam (ANRS 12229 PAANTHER 01 Study), underwent clinical assessment, chest radiography, Quantiferon Gold In-Tube (QFT), abdominal ultrasonography, and sample collection for microbiology, including Xpert MTB/RIF (Xpert). We developed 4 tuberculosis diagnostic models using logistic regression: (1) all predictors included, (2) QFT excluded, (3) ultrasonography excluded, and (4) QFT and ultrasonography excluded. We internally validated the models using resampling. We built a score on the basis of the model with the best area under the receiver operating characteristic curve and parsimony.

RESULTS: A total of 438 children were enrolled in the study; 251 (57.3%) had tuberculosis, including 55 (12.6%) with culture- or Xpert-confirmed tuberculosis. The final 4 models included Xpert, fever lasting >2 weeks, unremitting cough, hemoptysis and weight loss in the past 4 weeks, contact with a patient with smear-positive tuberculosis, tachycardia, miliary tuberculosis, alveolar opacities, and lymph nodes on the chest radiograph, together with abdominal lymph nodes on the ultrasound and QFT results. The areas under the receiver operating characteristic curves were 0.866, 0.861, 0.850, and 0.846, for models 1, 2, 3, and 4, respectively. The score developed on model 2 had a sensitivity of 88.6% and a specificity of 61.2% for a tuberculosis diagnosis.

CONCLUSIONS: Our score had a good diagnostic performance. Used in an algorithm, it should enable prompt treatment decision in children with suspected tuberculosis and a high mortality risk, thus contributing to significant public health benefits.

  • Abbreviations:
    ART —
    antiretroviral therapy
    AUROC —
    area under the receiver operating characteristic curve
    CI —
    confidence interval
    CXR —
    chest radiograph/radiography
    QFT —
    Quantiferon Gold In-Tube
    TST —
    tuberculin skin test
    WAZ —
    weight-for-age z score
    WHO —
    World Health Organization
    Xpert —
    Xpert MTB/RIF
  • What’s Known on This Subject:

    Despite their potential diagnostic value, the numerous scores and classifications developed to help standardize diagnosis of tuberculosis in children are not currently recommended in the World Health Organization childhood tuberculosis guidance because of their heterogeneity, lack of validation, and poor performance in children infected with HIV.

    What This Study Adds:

    We developed a score that was based on Xpert MTB/RIF, easily collected clinical features, chest radiograph features, and abdominal ultrasonography. With a sensitivity of 89% and a specificity of 61%, our score could enable early treatment decision in most HIV-infected children with tuberculosis.

    Tuberculosis is the leading cause of death in children infected with HIV worldwide, accounting for one-third of all deaths in this group.1,2 Diagnosis is a major challenge in childhood tuberculosis because of the low sensitivity of microbiologic examinations resulting from the paucibacillary nature of the disease and the difficulty to self-expectorate in children, the lack of a point-of-care test, and the limitations of clinical approaches.3 Underdiagnosis leads to poor access to treatment and subsequent mortality.4 In recent mathematical modeling, it was estimated that of 239 000 pediatric tuberculosis deaths every year, >96% occurred in children not receiving antituberculosis treatment.5

    Diagnostic challenges are greater in children infected with HIV.6 Microbiologic diagnosis, including with the World Health Organization (WHO)–endorsed Xpert MTB/RIF (Xpert) assay, performs similarly in both children infected with HIV and HIV-uninfected children, but clinical and radiologic features lack specificity in the context of severe immunodeficiency, frequent opportunistic infections, and HIV infection itself.6–8 Furthermore, immunodeficiency reduces sensitivity of immunologic tests for tuberculosis infection.9,10 Poor access to antituberculosis treatment is also responsible for a large part of tuberculosis-related mortality in children infected with HIV. Of 40 000 tuberculosis-related deaths in children infected with HIV, an estimated 90% occurred in children not receiving antituberculosis treatment.1,5

    Initiation of antituberculosis treatment significantly reduces mortality in HIV-infected children with confirmed and unconfirmed tuberculosis. It is, however, frequently followed by delays in antiretroviral therapy (ART) despite the WHO recommendation to initiate ART as soon as possible in children with tuberculosis. This is a serious issue because ART is associated with major reduction in mortality when started during the first month of follow-up.11,12 Xpert could enable quick diagnostic confirmation and treatment decision in children with high bacillary load who are most at risk of dying.12 In others, optimized algorithms or scoring systems for empirical antituberculosis treatment decision will help clinicians initiate treatment appropriately and accelerate initiation of ART.

    Various scoring systems and diagnostic approaches have been developed for tuberculosis diagnosis in children.13,14 However, these approaches lack coherence, standard definition of symptoms, and adequate validation and perform poorly in children infected with HIV.13–15 Although still in use in some countries, these scores are currently not recommended by the WHO.16,17 A recent study, however, revealed the potential for tuberculosis diagnosis, in children infected with HIV, of several diagnostic systems, including the historical Kenneth Jones criteria, and others used in South Africa, in Brazil, and previously in WHO studies.18–22

    We aimed to build a diagnostic prediction score and algorithm for antituberculosis treatment decision in HIV-infected children with suspected tuberculosis on the basis of microbiologic, clinical, and radiologic features. We assessed whether the Quantiferon Gold In-Tube (QFT) (Qiagen, Hilden, Germany), an interferon-γ release assay that can replace the tuberculin skin test (TST) for the diagnosis of tuberculosis infection, and abdominal ultrasonography, whose diagnostic value has been shown for tuberculosis in adults and children infected with HIV, had an added value on this score.9,23,24

    Methods

    The ANRS 12229 PAANTHER 01 Study was a cohort study aimed at developing an algorithm to improve diagnosis of tuberculosis in children infected with HIV that was conducted in 8 hospitals in Burkina Faso, Cambodia, Cameroon, and Vietnam (April 2011–December 2014) (Supplemental Methods section of the Supplemental Information). Inclusion procedures and the study design have been described elsewhere.25 In brief, we enrolled HIV-infected children aged ≤13 years with suspected tuberculosis on the basis of at least 1 of the following: (1) persistent cough; (2) fever for >2 weeks; (3) failure to thrive, defined as recent deviation in the growth curve or a weight-for-age z score (WAZ) <−2 SDs; (4) failure of antibiotics for a pulmonary infection; or (5) a suggestive chest radiograph (CXR). We excluded those with antituberculosis treatment started within 2 years before inclusion.

    The study was approved by relevant national ethics committees, institutional review boards, and national authorities. The ANRS 12229 PAANTHER 01 Study is registered at ClinicalTrials.gov (identifier NCT01331811).

    Procedures and Definitions

    After parent or guardian informed consent, a detailed history on presence and duration of symptoms 4 weeks before enrollment was collected from parent(s) or guardian(s) through a standardized questionnaire. Cough patterns were characterized by using a graphic illustration shown to parent(s) or guardian(s).26 All children had a complete physical examination; CXR, abdominal ultrasonography, and TST performed; and blood samples collected for HIV RNA, CD4, complete blood cell count, transaminases, and QFT. Each child had 2 to 3 gastric aspirates or expectorated sputa, 1 nasopharyngeal aspirate, 1 stool sample, and 1 string test, if aged ≥4 years, collected over a period of 3 days for Xpert, smear microscopy, and a mycobacterial culture.25 ART and antituberculosis treatment were initiated at the discretion of the treating physician. All children were followed-up for 6 months. All data were collected by using standardized paper case-report forms and entered in an online database developed on the Voozanoo software (Epiconcept, Paris, France).

    At the end of the study, children were retrospectively classified as having confirmed, unconfirmed, or unlikely tuberculosis by using the updated Clinical Case Definition for Classification of Intrathoracic Tuberculosis (Supplemental Table 4).27 For model development, the reference diagnosis was tuberculosis, defined either as confirmed or unconfirmed. CXRs were reviewed independently by 2 readers blinded to patient data; discordant opinions were resolved by a third reader. Results of the TST were considered positive if the transverse diameter of induration, read at 48 to 72 hours, was >5 mm. QFT results, interpreted per the manufacturer’s recommendation, were not taken into account for the reference diagnosis. We used age-defined standards for tachycardia and tachypnea (Supplemental Table 5).28 Sample-size calculations are detailed in the Supplemental Methods section of the Supplemental Information.

    Statistical Analysis

    We compared baseline characteristics between groups using Student’s t test or the Kruskal-Wallis test and Pearson’s χ2 or Fisher’s exact test, as appropriate.

    We used logistic regression to develop diagnostic prediction models for tuberculosis. We restricted the analysis to those children with data available for candidate predictors. We included, as candidate predictors, characteristics used in previous childhood tuberculosis scoring systems and characteristics previously described as associated with tuberculosis in children infected with HIV as well as QFT and abdominal ultrasonography results (Supplemental Methods section of the Supplemental Information).22,23,29–34 To identify additional predictors, we performed a nested case-control study, selecting as case patients all children with culture-confirmed tuberculosis and as controls those with unlikely tuberculosis who were still alive at month 6 and had not been treated for tuberculosis. We included as predictors CXR features, as assessed by the local reader. We tested various symptom durations (>2, >3, and >4 weeks) in the models and selected the one with the best Akaike information criterion. We also included ART and immunodeficiency as predictors in the models and tested interactions with other predictors.

    To account for the fact that QFT and abdominal ultrasonography may not be systematically available in low- and middle-income countries (because they were not recommended by the WHO for tuberculosis diagnosis), we developed 4 different models: (1) all predictors integrated, (2) QFT excluded, (3) abdominal ultrasonography excluded, and (4) both QFT and abdominal ultrasonography excluded. We obtained final models by stepwise backward selection. As recommended for prediction models, we used less stringent P values of <.157 or .135 when incorporating variables with 1 or 2 degrees of freedom to avoid overfitting and to reduce model optimism.35 We included Xpert and smear microscopy results secondarily in final models using Firth’s penalized likelihood to solve the problem of data separation.36 We performed internal validation using bootstrap resampling (Supplemental Methods section of the Supplemental Information).35

    We compared areas under the receiver operating characteristic curves (AUROCs) of models obtained and selected the best model on the basis of discriminative ability and parsimony. We developed an associated diagnostic score by assigning to each variable category a predictor score equal to its β coefficient in the model. We set the tuberculosis diagnosis threshold using a predicted probability cutoff that reached a sensitivity of 90% in the case-control subpopulation. To facilitate final score calculations, we multiplied all predictor scores by a factor setting the threshold to 100 (Supplemental Table 12).

    We assessed diagnostic performance of the score obtained in the whole cohort, considering missing data for predictors as all negative or all positive. Finally, we proposed a diagnostic algorithm that included the score.

    We performed all analyses using SAS software version 9.3 (SAS Institute, Inc, Cary, NC).

    Results

    We enrolled 438 children in the study (Table 1). Tuberculosis was confirmed by culture and/or Xpert in 55 (12.6%) children, and 196 (44.7%) children were classified as having unconfirmed tuberculosis, for a total of 251 (57.3%) children with tuberculosis.

    View this table:
    • View inline
    • View popup
    TABLE 1

    Characteristics of Children Enrolled in the Study

    Individual predictors with the best sensitivity for tuberculosis diagnosis were cough in the previous 4 weeks, cough lasting >2 weeks, cough in the past 24 hours, fever in the previous 4 weeks, and weight loss, as reported by the parent(s) or guardian(s), in the previous 4 weeks (Table 2). Specificities of these signs were poor overall.

    View this table:
    • View inline
    • View popup
    TABLE 2

    Diagnostic Accuracy of Tuberculosis Tests and Predictors After Full Clinical Evaluation

    Diagnostic Prediction Models

    A total of 335 of 438 children had data available for all selected predictors and were included in model development, including 201 (60.0%) children with tuberculosis and 134 (40.0%) who were classified as not having tuberculosis. Compared with children who were not included in model development, children with all predictors available were older, had a higher WAZ and higher hemoglobin count, more frequently had nontuberculous mycobacteria isolated, and had antituberculosis treatment initiated, and their risk of death was lower (Supplemental Tables 6 and 7).

    Of predictors associated with tuberculosis diagnosis in the case-control subanalysis, which included 45 culture-confirmed tuberculosis cases and 153 control cases (Supplemental Results section of the Supplemental Information, Supplemental Tables 8 and 9), tachycardia only was not part of our initial list of predictors considered (Supplemental Table 10).

    An identical set of 9 predictors remained in the 4 models: fever lasting >2 weeks, unremitting cough, hemoptysis and weight loss in the previous 4 weeks, contact with a patient with smear-positive tuberculosis, tachycardia, miliary tuberculosis, alveolar opacities, and lymph nodes on the CXR (Supplemental Table 11). ART and immunodeficiency did not improve model predictions and thus were not included in the final model; QFT results and abdominal lymph nodes on the ultrasound were ultimately included in the final models because they improved model predictions significantly. There was no interaction between ART or immunodeficiency and other predictors.

    AUROCs for models 1, 2, 3, and 4 were 0.839 (95% confidence interval [CI] 0.797–0.880), 0.830 (95% CI 0.787–0.873), 0.819 (95% CI 0.775–0.863), and 0.808 (95% CI 0.762–0.853), respectively. Compared with model 1, only model 4 had a significantly lower discriminative ability (P = .220, P = .072, and P = .0191 for models 2, 3, and 4, respectively).

    Models Integrating Smear Microscopy and Xpert

    Including smear microscopy as a predictor did significantly change the discriminative ability of models 1, 2, and 3, compared with models without smear microscopy. It only led to a significant AUROC increase for model 4 (Supplemental Results section of the Supplemental Information). Including Xpert in the final models led to better discriminative ability for all models, with significant increases in AUROCs to 0.866 (95% CI 0.829–0.904), 0.861 (95% CI 0.822–0.899), 0.850 (95% CI 0.809–0.890), and 0.846 (95% CI 0.805–0.887) for models 1, 2, 3, and 4, respectively, compared with models without Xpert (P = .0015, P = .0011, P = .0007, and P = .0002) (Fig 1), without changes in other model predictors selected (Table 3). Compared with model 1, only model 4 had a significantly lower discriminative ability (P = .2800, P = .0799, and P = .0499 for models 2, 3, and 4, respectively). Model optimism was estimated to 0.0584 (95% CI 0.0147–0.0872) for model 2, which had the best discriminative ability and parsimony.

    FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Receiver operating characteristic (ROC) curves for comparisons of 4 tuberculosis diagnostic prediction models with Xpert: (1) model 1 integrated all predictors, (2) model 2 excluded QFT, (3) model 3 excluded abdominal ultrasonography, and (4) model 4 excluded both QFT and abdominal ultrasonography.

    View this table:
    • View inline
    • View popup
    TABLE 3

    Prediction Models Integrating Xpert Results

    Performance of the Scores

    The score was developed on model 2 (Supplemental Table 13) by using the predicted probability cutoff that obtained a sensitivity >90% in the case-control population (Supplemental Figs 3 and 4, Supplemental Table 12). It had the following diagnostic accuracy measures: sensitivity: 178 of 201 (88.6%; 95% CI 84.2%–93.0%); specificity: 82 of 134 (61.2%; 95% CI 52.9%–69.4%); positive predictive value: 77.4% (95% CI 72.0%–82.8%); negative predictive value: 78.1% (95% CI 70.2%–86.0%).

    The score sensitivity did not differ between the 4 countries (P = .144); specificities were significantly lower in Cambodia and Cameroon (43.3% [95% CI 25.6%–61.1%]; 40% [95% CI 23.8%–56.2%]; P < .0001) (Supplemental Results section of the Supplemental Information). Sensitivity did not differ between patients with a CD4 percentage <10% and those with a CD4 percentage ≥10% (P = .568); specificity was lower in those with a CD4 percentage <10% (53.1%; 95% CI 39.1%–67.0%; P = .014). Sensitivity and specificity did not differ between children with chronic cough as an inclusion criterion and the others (P = .838 and P = .485).

    The score applied to the overall cohort correctly identified 228 (85.7%) children with tuberculosis and 116 (62.0%) children without tuberculosis when all missing predictors were considered as negative. Conversely, when all missing data were considered as positive, it correctly identified 228 (90.8%) children with tuberculosis and 82 (43.9%) children without tuberculosis.

    PAANTHER Algorithm

    In children infected with HIV presenting with a clinical suspicion of tuberculosis based either on chronic cough for >2 weeks or other study eligibility criteria, including a suggestive CXR (if done previously), the score can be applied in a stepwise approach (Fig 2). Antituberculosis treatment should be initiated immediately in children with a score of >100. Tuberculosis may be ruled out in children who score below 100 after full assessment, with a recommended subsequent clinical reassessment for persistent symptoms. If abdominal ultrasonography cannot be available, an alternative score may be used (Supplemental Table 14), with a sensitivity of 90.0% (95% CI 85.9%–94.2%) but a lower specificity of 48.5% (95% CI 40.0%–57.0%).

    FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Proposed PAANTHER tuberculosis (TB) treatment-decision algorithm, including the diagnostic score.

    Discussion

    We developed a diagnostic prediction score for antituberculosis treatment decision in HIV-infected children with suspected tuberculosis. We aimed to provide clinicians from high–tuberculosis burden and resource-limited settings with a decision-making tool to initiate antituberculosis treatment quickly in HIV-infected children with suspected tuberculosis. The score obtained had a sensitivity of ∼90% and a specificity of 61%.

    To our knowledge, this is the first study in which a diagnostic score is developed exclusively in children infected with HIV by using methods recommended for diagnostic prediction models. Previous pediatric tuberculosis diagnostic scores and algorithms were mostly based on expert opinion and often lacked validation.13,14 A prospective study in South Africa revealed that the combined presence of 3 symptoms constituted a good tuberculosis diagnostic approach in HIV-uninfected children aged ≥3 years, but it performed poorly in those infected by HIV (sensitivity: 56%; specificity: 62%).22 Recently, a retrospective study of scoring systems in Brazilian children infected with HIV who were evaluated for tuberculosis revealed that an extended version of the South African approach had a sensitivity of 94% or 84%, depending on whether a microbiologic evaluation was included in the evaluation, and a specificity of 30%.18 Our score therefore has good performances overall, compared with these scoring systems, with a good sensitivity and an acceptable specificity if Xpert is used. Despite increasing availability of the GeneXpert platform in high–tuberculosis burden countries, access to Xpert may still be challenging in some resource-limited settings.37

    The vast majority of children had prolonged cough as an inclusion criterion, which therefore lacked specificity. However, unremitting cough, which was assessed by using a graphic illustration, revealed a much higher specificity and remained in the model. Tachycardia, which was not used before in pediatric tuberculosis scores, is part of the 3 danger signs that should trigger antituberculosis treatment initiation in severely ill adults infected with HIV.38 CXR findings significantly contributed to our score; yet, there is limited access to quality CXR and lack of reading skills in limited-resource settings. We used the local reader’s opinion, which constituted an imperfect but more practical test compared with more experienced readers.39 Presence of lymph nodes on the ultrasound had similar diagnostic accuracy compared with that found in South African children infected with HIV and significantly improved the model’s discriminative ability.23,24 Sensitivity of QFT in our study was much lower than the pooled sensitivity estimated at 47% in a recent meta-analysis in children infected with HIV and did not improve the model’s discriminative ability, confirming its poor diagnostic performance for tuberculosis in children with immunodeficiency.9

    With its high sensitivity, our score should enable standardized treatment initiation in most HIV-infected children with tuberculosis. We showed previously that mortality in ART-naïve children was associated with the lack of treatment rather than the delay to antituberculosis treatment.12 However, initiation of antituberculosis treatment within a median of 1 week led to delayed ART, which was associated with increased mortality. It was recently estimated that in high–tuberculosis burden countries, it may be more cost-effective to treat all children with presumptive tuberculosis.40 In children infected with HIV, however, pill burden and potential impact on ART have led to a call for a more discriminant approach. With the step-by-step approach, the score could enable same-day treatment decision without CXR and abdominal ultrasonography in children presenting clinical criteria. Overall, our score did not perform as well as clinicians from study tertiary health care facilities who treated 92% of children with tuberculosis and only 6% of those without; however, we expect that it will contribute to faster treatment decision at lower levels of care, especially when used with feasible and sensitive specimens for Xpert, such as nasopharyngeal aspirates and stools.25 In practice, access to treatment does not depend exclusively on treatment decision and may be delayed for other structural reasons.

    Our study has limitations. First, an incorporation bias resulting from the lack of a reference standard for childhood tuberculosis, independent from candidate predictors, may have led to overestimation of the models’ diagnostic performance.41 The good discriminative ability of the model in the case-control subset, however, reveals limited impact on the score performances. Second, almost one-quarter of study participants, mostly younger children with severe clinical status, had missing data for the considered predictors. Our analysis reveals, however, that the score has similar sensitivity in these children and that missing data would mostly impact specificity, which varied between 43% and 61%. Lastly, our study eligibility criteria differed from WHO criteria for investigation of tuberculosis, namely poor weight gain, fever, current cough, and history of contact with a patient with tuberculosis.42 Our score is therefore not directly applicable to children presenting with these criteria. Despite these limitations our study has strengths. Development by using data from 4 countries ensured better external validity and generalizability of the scores, and internal validation revealed that the models developed would provide good predictions.43 The lower score specificity in Cambodia could be due to higher rates of nontuberculous mycobacteria disease, which is difficult to distinguish from tuberculosis.44

    Conclusions

    With its high sensitivity and algorithmic approach, the PAANTHER score should enable rapid treatment decision in children with presumptive tuberculosis. This algorithm constitutes a consequentialist approach to tuberculosis in children infected with HIV, considering the need to initiate treatment to reduce mortality, rather than an essentialist approach, considering the trueness of tuberculosis diagnosis.45 However, further external validation is needed to validate both the scoring system and the overall approach and to confirm its clinical usefulness.

    Acknowledgments

    We thank all children and their parents and caregivers for their participation in the study, national tuberculosis and HIV programs from participating countries for their support, Françoise Barré-Sinoussi and Jean-François Delfraissy for their continuous support, Xavier Anglaret for general guidance, Julien Asselineau and Paul Perez for methodologic advice, and Corine Chazallon and Vincent Bouteloup for statistical support.

    Footnotes

      • Accepted June 3, 2019.
    • Address correspondence to Olivier Marcy, MD, PhD, Equipe IDLIC, Bordeaux Population Health Centre U1219, Université de Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux, France. E-mail: olivier.marcy{at}u-bordeaux.fr
    • This trial has been registered at www.clinicaltrials.gov (identifier NCT01331811).

    • COMPANION PAPER: A companion to this article can be found online at www.pediatrics.org/cgi/doi/10.1542/peds.2019-1797.

    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: Funded by the ANRS (ANRS 12229) and Fondation Total.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    References

    1. ↵
      UNAIDS. Children and HIV: Fact Sheet. Geneva, Switzerland: UNAIDS; 2016
    2. ↵
      World Health Organization. Global Tuberculosis Report 2017. Geneva, Switzerland: World Health Organization; 2017
    3. ↵
      1. Marais BJ,
      2. Graham SM,
      3. Maeurer M,
      4. Zumla A
      . Progress and challenges in childhood tuberculosis. Lancet Infect Dis. 2013;13(4):287–289
      OpenUrlCrossRefPubMed
    4. ↵
      1. Jenkins HE,
      2. Yuen CM,
      3. Rodriguez CA, et al
      . Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(3):285–295
      OpenUrlPubMed
    5. ↵
      1. Dodd PJ,
      2. Yuen CM,
      3. Sismanidis C,
      4. Seddon JA,
      5. Jenkins HE
      . The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5(9):e898–e906
      OpenUrlPubMed
    6. ↵
      1. Marais BJ,
      2. Graham SM,
      3. Cotton MF,
      4. Beyers N
      . Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis. 2007;196(suppl 1):S76–S85
      OpenUrlCrossRefPubMed
      1. Detjen AK,
      2. DiNardo AR,
      3. Leyden J, et al
      . Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(6):451–461
      OpenUrl
    7. ↵
      1. Swaminathan S
      . Tuberculosis in HIV-infected children. Paediatr Respir Rev. 2004;5(3):225–230
      OpenUrlCrossRefPubMed
    8. ↵
      1. Sollai S,
      2. Galli L,
      3. de Martino M,
      4. Chiappini E
      . Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update. BMC Infect Dis. 2014;14(suppl 1):S6
      OpenUrlCrossRefPubMed
    9. ↵
      1. Madhi SA,
      2. Gray GE,
      3. Huebner RE,
      4. Sherman G,
      5. McKinnon D,
      6. Pettifor JM
      . Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J. 1999;18(9):800–805
      OpenUrlCrossRefPubMed
    10. ↵
      World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. Geneva, Switzerland: World Health Organization; 2016
    11. ↵
      1. Marcy O,
      2. Tejiokem M,
      3. Msellati P, et al
      ; ANRS 12229 PAANTHER 01 Study Group. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018;5(2):e87–e95
      OpenUrl
    12. ↵
      1. Hesseling AC,
      2. Schaaf HS,
      3. Gie RP,
      4. Starke JR,
      5. Beyers N
      . A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002;6(12):1038–1045
      OpenUrlPubMed
    13. ↵
      1. Pearce EC,
      2. Woodward JF,
      3. Nyandiko WM,
      4. Vreeman RC,
      5. Ayaya SO
      . A systematic review of clinical diagnostic systems used in the diagnosis of tuberculosis in children. AIDS Res Treat. 2012;2012:401896
      OpenUrlPubMed
    14. ↵
      1. Edwards DJ,
      2. Kitetele F,
      3. Van Rie A
      . Agreement between clinical scoring systems used for the diagnosis of pediatric tuberculosis in the HIV era. Int J Tuberc Lung Dis. 2007;11(3):263–269
      OpenUrlPubMed
    15. ↵
      World Health Organization. Guidance for National Tuberculosis Programmes in the Management of Tuberculosis in Children. 2nd ed. Geneva, Switzerland: World Health Organization; 2014
    16. ↵
      World Health Organization; International Union Against Tuberculosis and Lung Diseases. Guidance for National Tuberculosis and HIV Programmes on the Management of Tuberculosis in HIV-Infected Children. Recommendations for a Public Health Approach. Paris, France: International Union Against Tuberculosis and Lung Disease (The Union); 2010
    17. ↵
      1. David SG,
      2. Lovero KL,
      3. Pombo March MFB, et al
      ; Rede-TB Study Group. A comparison of tuberculosis diagnostic systems in a retrospective cohort of HIV-infected children in Rio de Janeiro, Brazil. Int J Infect Dis. 2017;59:150–155
      OpenUrl
      1. Stegen G,
      2. Jones K,
      3. Kaplan P
      . Criteria for guidance in the diagnosis of tuberculosis. Pediatrics. 1969;43(2):260–263
      OpenUrlAbstract/FREE Full Text
      1. Tidjani O,
      2. Amedome A,
      3. ten Dam HG
      . The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle. 1986;67(4):269–281
      OpenUrlCrossRefPubMed
    18. Ministério da Saúde, Fundação Nacional de Saúde. Tuberculose: Guia de Vigilância Epidemiológica. Brasilia, Brazil: Ministério da Saúde; 2002
    19. ↵
      1. Marais BJ,
      2. Gie RP,
      3. Hesseling AC, et al
      . A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics. 2006;118(5). Available at: www.pediatrics.org/cgi/content/full/118/5/e1350
    20. ↵
      1. Sculier D,
      2. Vannarith C,
      3. Pe R, et al
      . Performance of abdominal ultrasound for diagnosis of tuberculosis in HIV-infected persons living in Cambodia. J Acquir Immune Defic Syndr. 2010;55(4):500–502
      OpenUrlCrossRefPubMed
    21. ↵
      1. Bélard S,
      2. Heller T,
      3. Orie V, et al
      . Sonographic findings of abdominal tuberculosis in children with pulmonary tuberculosis. Pediatr Infect Dis J. 2017;36(12):1224–1226
      OpenUrl
    22. ↵
      1. Marcy O,
      2. Ung V,
      3. Goyet S, et al
      . Performance of Xpert MTB/RIF and alternative specimen collection methods for the diagnosis of tuberculosis in HIV-infected children. Clin Infect Dis. 2016;62(9):1161–1168
      OpenUrlCrossRefPubMed
    23. ↵
      1. Marais BJ,
      2. Gie RP,
      3. Obihara CC,
      4. Hesseling AC,
      5. Schaaf HS,
      6. Beyers N
      . Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child. 2005;90(11):1162–1165
      OpenUrlAbstract/FREE Full Text
    24. ↵
      1. Graham SM,
      2. Cuevas LE,
      3. Jean-Philippe P, et al
      . Clinical case definitions for classification of intrathoracic tuberculosis in children: an update. Clin Infect Dis. 2015;61(suppl 3):S179–S187
      OpenUrlCrossRefPubMed
    25. ↵
      1. Fleming S,
      2. Thompson M,
      3. Stevens R, et al
      . Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377(9770):1011–1018
      OpenUrlCrossRefPubMed
    26. ↵
      World Health Organization. Management of the Child With a Serious Infection or Severe Malnutrition: Guidelines for Care at the First-Referral Level in Developing Countries. Geneva, Switzerland: Department of Child and Adolescent Health and Development, World Health Organization; 2000
      1. Kiwanuka J,
      2. Graham SM,
      3. Coulter JB, et al
      . Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr. 2001;21(1):5–14
      OpenUrlPubMed
      1. Harries A,
      2. Maher D,
      3. Graham S
      . TB/HIV: A Clinical Manual. 2nd ed. Geneva, Switzerland: World Health Organization; 2004
      1. Harries A,
      2. Maher D
      . TB/HIV: A Clinical Manual. 1st ed. Geneva, Switzerland: World Health Organization; 1996
      1. Edwards K
      . The diagnosis of childhood tuberculosis. P N G Med J. 1987;30(2):169–178
      OpenUrlPubMed
    27. ↵
      1. Pedrozo C,
      2. Sant’Anna C,
      3. de Fátima March M,
      4. Lucena S
      . Clinical scoring system for paediatric tuberculosis in HIV-infected and non-infected children in Rio de Janeiro. Int J Tuberc Lung Dis. 2009;13(3):413–415
      OpenUrlPubMed
    28. ↵
      1. Steyerberg EW
      . Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2009
    29. ↵
      1. Heinze G,
      2. Schemper M
      . A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409–2419
      OpenUrlCrossRefPubMed
    30. ↵
      1. Cazabon D,
      2. Pande T,
      3. Kik S, et al
      . Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: a trend analysis from 2014 - 2016. Gates Open Res. 2018;2:35
      OpenUrl
    31. ↵
      1. Katagira W,
      2. Walter ND,
      3. Den Boon S, et al
      . Empiric TB treatment of severely ill patients with HIV and presumed pulmonary TB improves survival. J Acquir Immune Defic Syndr. 2016;72(3):297–303
      OpenUrl
    32. ↵
      1. Berteloot L,
      2. Marcy O,
      3. Nguyen B, et al
      . Value of chest x-ray in TB diagnosis in HIV-infected children living in resource-limited countries: the ANRS 12229-PAANTHER 01 study. Int J Tuberc Lung Dis. 2018;22(8):844–850
      OpenUrl
    33. ↵
      1. Debes AK,
      2. Gilman RH,
      3. Onyango-Makumbi C,
      4. Ruff A,
      5. Oberhelman R,
      6. Dowdy DW
      . Cost-effectiveness of diagnostic algorithms for tuberculosis in children less than 5 years of age. Pediatr Infect Dis J. 2017;36(1):36–43
      OpenUrlCrossRef
    34. ↵
      1. Whiting P,
      2. Rutjes AW,
      3. Reitsma JB,
      4. Glas AS,
      5. Bossuyt PM,
      6. Kleijnen J
      . Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004;140(3):189–202
      OpenUrlCrossRefPubMed
    35. ↵
      World Health Organization. Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings. Geneva, Switzerland: World Health Organization, Department of HIV/AIDS, Stop TB Department; 2011
    36. ↵
      1. Moons KG,
      2. Altman DG,
      3. Reitsma JB, et al
      . Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–W73
      OpenUrlCrossRefPubMed
    37. ↵
      1. Borand L,
      2. de Lauzanne A,
      3. Nguyen NL, et al
      ; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. Isolation of nontuberculous mycobacteria in Southeast Asian and African human immunodeficiency virus-infected children with suspected tuberculosis. Clin Infect Dis. 2019;68(10):1750–1753
      OpenUrl
    38. ↵
      1. Bossuyt PMM
      . The architecture of medical test evaluations. 2012. Available at: http://assr.regione.emilia-romagna.it/it/eventi/2012/to-see-or-not-to-see/Bossuyt_architecture.pdf/at_download/file/Bossuyt_architecture.pdf. Accessed June 15, 2018
    • Copyright © 2019 by the American Academy of Pediatrics
    PreviousNext
    Back to top

    Advertising Disclaimer »

    In this issue

    Pediatrics
    Vol. 144, Issue 3
    1 Sep 2019
    • Table of Contents
    • Index by author
    View this article with LENS
    PreviousNext
    Email Article

    Thank you for your interest in spreading the word on American Academy of Pediatrics.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis
    (Your Name) has sent you a message from American Academy of Pediatrics
    (Your Name) thought you would like to see the American Academy of Pediatrics web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Request Permissions
    Article Alerts
    Log in
    You will be redirected to aap.org to login or to create your account.
    Or Sign In to Email Alerts with your Email Address
    Citation Tools
    A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis
    Olivier Marcy, Laurence Borand, Vibol Ung, Philippe Msellati, Mathurin Tejiokem, Khanh Truong Huu, Viet Do Chau, Duong Ngoc Tran, Francis Ateba-Ndongo, Suzie Tetang-Ndiang, Boubacar Nacro, Bintou Sanogo, Leakhena Neou, Sophie Goyet, Bunnet Dim, Polidy Pean, Catherine Quillet, Isabelle Fournier, Laureline Berteloot, Guislaine Carcelain, Sylvain Godreuil, Stéphane Blanche, Christophe Delacourt, ANRS 12229 PAANTHER 01 STUDY GROUP
    Pediatrics Sep 2019, 144 (3) e20182065; DOI: 10.1542/peds.2018-2065

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis
    Olivier Marcy, Laurence Borand, Vibol Ung, Philippe Msellati, Mathurin Tejiokem, Khanh Truong Huu, Viet Do Chau, Duong Ngoc Tran, Francis Ateba-Ndongo, Suzie Tetang-Ndiang, Boubacar Nacro, Bintou Sanogo, Leakhena Neou, Sophie Goyet, Bunnet Dim, Polidy Pean, Catherine Quillet, Isabelle Fournier, Laureline Berteloot, Guislaine Carcelain, Sylvain Godreuil, Stéphane Blanche, Christophe Delacourt, ANRS 12229 PAANTHER 01 STUDY GROUP
    Pediatrics Sep 2019, 144 (3) e20182065; DOI: 10.1542/peds.2018-2065
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts
    • Table of Contents

    Jump to section

    • Article
      • Abstract
      • Methods
      • Results
      • Discussion
      • Conclusions
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Supplemental
    • Info & Metrics
    • Comments

    Related Articles

    • PubMed
    • Google Scholar

    Cited By...

    • Minding (and Reducing) the Detection Gap: An Algorithm to Diagnose TB With HIV Infection
    • Google Scholar

    More in this TOC Section

    • Applications of Artificial Intelligence for Retinopathy of Prematurity Screening
    • Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome
    • Severe Acute Neurologic Involvement in Children With Hemolytic-Uremic Syndrome
    Show more Article

    Similar Articles

    Subjects

    • Infectious Disease
      • Infectious Disease
      • HIV/AIDS
    • Journal Info
    • Editorial Board
    • Editorial Policies
    • Overview
    • Licensing Information
    • Authors/Reviewers
    • Author Guidelines
    • Submit My Manuscript
    • Open Access
    • Reviewer Guidelines
    • Librarians
    • Institutional Subscriptions
    • Usage Stats
    • Support
    • Contact Us
    • Subscribe
    • Resources
    • Media Kit
    • About
    • International Access
    • Terms of Use
    • Privacy Statement
    • FAQ
    • AAP.org
    • shopAAP
    • Follow American Academy of Pediatrics on Instagram
    • Visit American Academy of Pediatrics on Facebook
    • Follow American Academy of Pediatrics on Twitter
    • Follow American Academy of Pediatrics on Youtube
    • RSS
    American Academy of Pediatrics

    © 2021 American Academy of Pediatrics